• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CXCL13-CXCR5轴通过PI3K/AKT途径促进结肠癌细胞的生长和侵袭。

CXCL13-CXCR5 axis promotes the growth and invasion of colon cancer cells via PI3K/AKT pathway.

作者信息

Zhu Zhenyu, Zhang Xukui, Guo Hongliang, Fu Ling, Pan Ganlin, Sun Yinggang

机构信息

Surgiaca Ward 4 (Colorectum & Intestinal Surgery), Shandong Tumor Hospital, Jinan, 250117, Shandong, China.

出版信息

Mol Cell Biochem. 2015 Feb;400(1-2):287-95. doi: 10.1007/s11010-014-2285-y. Epub 2014 Dec 5.

DOI:10.1007/s11010-014-2285-y
PMID:25476740
Abstract

CXCL13, an inflammatory factor in the microenvironment, plays a vital role in the progression of inflammatory diseases and tumors. CXCL13 and its receptor CXCR5 have been reported to be associated with poor prognosis of advanced colon cancer. However, the molecular mechanisms of CXCL13-CXCR5 axis in colon cancer remain elusive. The aim of this study was to investigate the role of CXCR5-CXCL13 axis in the growth and invasion of colon cancer cells. Our results showed that CXCL13 promoted the growth, migration, and matrigel invasion of colon cancer cells. Furthermore, CXCL13 increased the expression and secretion of MMP-13, and stimulated the activation of PI3K/AKT pathway. After knockdown of CXCR5 by siRNA, the biological functions of colon cancer cells regulated by CXCL13 were significantly inhibited. In addition, inhibition of PI3K/AKT pathway by specific inhibitor LY294002 suppressed the CXCL13-mediated growth, migration, and invasion of colon cancer cells. Together, our findings suggest that CXCL13-CXCR5 axis promotes the growth, migration, and invasion of colon cancer cells, probably via PI3K/AKT pathway. Thus, CXCL13 may be a useful biomarker for the detection and treatment of colon cancer.

摘要

CXCL13是微环境中的一种炎症因子,在炎症性疾病和肿瘤的进展中起着至关重要的作用。据报道,CXCL13及其受体CXCR5与晚期结肠癌的不良预后相关。然而,CXCL13 - CXCR5轴在结肠癌中的分子机制仍不清楚。本研究的目的是探讨CXCR5 - CXCL13轴在结肠癌细胞生长和侵袭中的作用。我们的结果表明,CXCL13促进结肠癌细胞的生长、迁移和基质胶侵袭。此外,CXCL13增加MMP - 13的表达和分泌,并刺激PI3K/AKT通路的激活。用siRNA敲低CXCR5后,CXCL13调节的结肠癌细胞的生物学功能受到显著抑制。此外,特异性抑制剂LY294002抑制PI3K/AKT通路可抑制CXCL13介导的结肠癌细胞的生长、迁移和侵袭。总之,我们的研究结果表明,CXCL13 - CXCR5轴可能通过PI3K/AKT通路促进结肠癌细胞的生长、迁移和侵袭。因此,CXCL13可能是结肠癌检测和治疗的一个有用的生物标志物。

相似文献

1
CXCL13-CXCR5 axis promotes the growth and invasion of colon cancer cells via PI3K/AKT pathway.CXCL13-CXCR5轴通过PI3K/AKT途径促进结肠癌细胞的生长和侵袭。
Mol Cell Biochem. 2015 Feb;400(1-2):287-95. doi: 10.1007/s11010-014-2285-y. Epub 2014 Dec 5.
2
ETV4 promotes pancreatic ductal adenocarcinoma metastasis through activation of the CXCL13/CXCR5 signaling axis.ETV4 通过激活 CXCL13/CXCR5 信号轴促进胰腺导管腺癌转移。
Cancer Lett. 2022 Jan 1;524:42-56. doi: 10.1016/j.canlet.2021.09.026. Epub 2021 Sep 25.
3
CXCL13-CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis.CXCL13-CXCR5 共表达调控乳腺癌细胞淋巴转移过程中的上皮间质转化。
Breast Cancer Res Treat. 2014 Jan;143(2):265-76. doi: 10.1007/s10549-013-2811-8. Epub 2013 Dec 13.
4
Protein Kinase C Epsilon Cooperates with PTEN Loss for Prostate Tumorigenesis through the CXCL13-CXCR5 Pathway.蛋白激酶Cε通过CXCL13-CXCR5途径与PTEN缺失协同作用促进前列腺肿瘤发生。
Cell Rep. 2017 Apr 11;19(2):375-388. doi: 10.1016/j.celrep.2017.03.042.
5
Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression.高 CXCL13-CXCR5 信使 RNA 表达的高危早期 HER2 阳性乳腺癌患者的转归改善。
Clin Breast Cancer. 2012 Jun;12(3):183-93. doi: 10.1016/j.clbc.2012.03.006.
6
Expression features of CXCR5 and its ligand, CXCL13 associated with poor prognosis of advanced colorectal cancer.CXCR5及其配体CXCL13的表达特征与晚期结直肠癌的不良预后相关。
Eur Rev Med Pharmacol Sci. 2014 Jul;18(13):1916-24.
7
CXC chemokine ligand-13 promotes metastasis via CXCR5-dependent signaling pathway in non-small cell lung cancer.CXC 趋化因子配体-13 通过 CXCR5 依赖性信号通路促进非小细胞肺癌转移。
J Cell Mol Med. 2021 Oct;25(19):9128-9140. doi: 10.1111/jcmm.16743. Epub 2021 Aug 24.
8
CXCL13/CXCR5 signaling axis in cancer.趋化因子配体 13/趋化因子受体 5 信号轴在癌症中的作用。
Life Sci. 2019 Jun 15;227:175-186. doi: 10.1016/j.lfs.2019.04.053. Epub 2019 Apr 23.
9
Altered Expression of CXCL13 and CXCR5 in Intractable Temporal Lobe Epilepsy Patients and Pilocarpine-Induced Epileptic Rats.CXCL13和CXCR5在难治性颞叶癫痫患者及匹罗卡品诱导的癫痫大鼠中的表达变化
Neurochem Res. 2017 Feb;42(2):526-540. doi: 10.1007/s11064-016-2102-y. Epub 2016 Nov 21.
10
Hypermethylation of Single CpG Dinucleotides at the Promoter of CXCL13 Gene Promoting Cell Migration in Cervical Cancer.CXCL13 基因启动子中单 CpG 二核苷酸的超甲基化促进宫颈癌中的细胞迁移。
Curr Cancer Drug Targets. 2020;20(5):355-363. doi: 10.2174/1568009620666200102123635.

引用本文的文献

1
Suppression of Hepatocellular Carcinoma through Apoptosis Induction by Total Alkaloids of Gelsemium elegans Benth.钩吻总生物碱通过诱导凋亡抑制肝癌
Chin J Integr Med. 2025 Mar 7. doi: 10.1007/s11655-025-4121-5.
2
Integrative multi-omics analysis of radionuclide-induced intestinal injury reveals the radioprotective role of L-citrulline through histone H3-mediated Cxcl3.放射性核素诱导的肠道损伤的整合多组学分析揭示了L-瓜氨酸通过组蛋白H3介导的Cxcl3发挥的辐射防护作用。
J Transl Med. 2025 Feb 14;23(1):180. doi: 10.1186/s12967-025-06197-9.
3
Serum CXCL13 as a Novel Biomarker in Oral Squamous Cell Carcinoma.

本文引用的文献

1
Expression features of CXCR5 and its ligand, CXCL13 associated with poor prognosis of advanced colorectal cancer.CXCR5及其配体CXCL13的表达特征与晚期结直肠癌的不良预后相关。
Eur Rev Med Pharmacol Sci. 2014 Jul;18(13):1916-24.
2
Colorectal cancer statistics, 2014.结直肠癌统计数据,2014 年。
CA Cancer J Clin. 2014 Mar-Apr;64(2):104-17. doi: 10.3322/caac.21220. Epub 2014 Mar 17.
3
CXCL13-CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis.CXCL13-CXCR5 共表达调控乳腺癌细胞淋巴转移过程中的上皮间质转化。
血清 CXCL13 作为口腔鳞状细胞癌的一种新型生物标志物。
Cancer Med. 2024 Sep;13(18):e70263. doi: 10.1002/cam4.70263.
4
Pre-metastatic niche: formation, characteristics and therapeutic implication.转移前生态位:形成、特征及治疗意义
Signal Transduct Target Ther. 2024 Sep 25;9(1):236. doi: 10.1038/s41392-024-01937-7.
5
Epigenetic targets to enhance antitumor immune response through the induction of tertiary lymphoid structures.通过诱导三级淋巴结构增强抗肿瘤免疫反应的表观遗传靶点。
Front Immunol. 2024 Jan 25;15:1348156. doi: 10.3389/fimmu.2024.1348156. eCollection 2024.
6
The Evolving Landscape of B Cells in Cancer Metastasis.癌症转移中 B 细胞的演变景观。
Cancer Res. 2023 Dec 1;83(23):3835-3845. doi: 10.1158/0008-5472.CAN-23-0620.
7
Identification and Interaction Analysis of Molecular Markers in Pancreatic Ductal Adenocarcinoma by Bioinformatics and Next-Generation Sequencing Data Analysis.基于生物信息学和二代测序数据分析的胰腺导管腺癌分子标志物鉴定及相互作用分析
Bioinform Biol Insights. 2023 Jul 25;17:11779322231186719. doi: 10.1177/11779322231186719. eCollection 2023.
8
A pyroptosis-related gene signature that predicts immune infiltration and prognosis in colon cancer.一种预测结肠癌免疫浸润和预后的焦亡相关基因特征。
Front Oncol. 2023 Jul 12;13:1173181. doi: 10.3389/fonc.2023.1173181. eCollection 2023.
9
Extracellular matrix-based gene signature for predicting prognosis in colon cancer and immune microenvironment.基于细胞外基质的基因特征用于预测结肠癌预后及免疫微环境
Transl Cancer Res. 2023 Feb 28;12(2):321-339. doi: 10.21037/tcr-22-2036. Epub 2023 Feb 15.
10
Identification of a tissue resident memory CD8 T cell-related risk score signature for colorectal cancer, the association with TME landscapes and therapeutic responses.鉴定一种用于结直肠癌的组织驻留记忆性CD8 T细胞相关风险评分特征,及其与肿瘤微环境格局和治疗反应的关联。
Front Genet. 2023 Jan 4;13:1088230. doi: 10.3389/fgene.2022.1088230. eCollection 2022.
Breast Cancer Res Treat. 2014 Jan;143(2):265-76. doi: 10.1007/s10549-013-2811-8. Epub 2013 Dec 13.
4
Antibody Microarray Analysis of Signaling Networks Regulated by Cxcl13 and Cxcr5 in Prostate Cancer.前列腺癌中由Cxcl13和Cxcr5调控的信号网络的抗体微阵列分析
J Proteomics Bioinform. 2012;5(8):177-184. doi: 10.4172/jpb.1000232.
5
Cell survival and metastasis regulation by Akt signaling in colorectal cancer.Akt 信号对结直肠癌中细胞存活和转移的调节。
Cell Signal. 2013 Aug;25(8):1711-9. doi: 10.1016/j.cellsig.2013.03.025. Epub 2013 Apr 18.
6
CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma.CXCL13 联合白细胞介素 10 对中枢神经系统淋巴瘤的诊断具有高度特异性。
Blood. 2013 Jun 6;121(23):4740-8. doi: 10.1182/blood-2013-01-476333. Epub 2013 Apr 9.
7
Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin B-cell lymphoma risk.趋化因子 CXCL13 的血清水平、CXCL13 及其受体 CXCR5 的遗传变异与 HIV 相关非霍奇金 B 细胞淋巴瘤风险。
Cancer Epidemiol Biomarkers Prev. 2013 Feb;22(2):295-307. doi: 10.1158/1055-9965.EPI-12-1122. Epub 2012 Dec 18.
8
Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression.高 CXCL13-CXCR5 信使 RNA 表达的高危早期 HER2 阳性乳腺癌患者的转归改善。
Clin Breast Cancer. 2012 Jun;12(3):183-93. doi: 10.1016/j.clbc.2012.03.006.
9
CXCL13 activation of c-Myc induces RANK ligand expression in stromal/preosteoblast cells in the oral squamous cell carcinoma tumor-bone microenvironment.CXCL13 通过激活 c-Myc 诱导口腔鳞状细胞癌细胞-骨微环境中的基质/前成骨细胞中 RANKL 的表达。
Oncogene. 2013 Jan 3;32(1):97-105. doi: 10.1038/onc.2012.24. Epub 2012 Feb 13.
10
Role of CXCL13 in asthma: novel therapeutic target.CXCL13 在哮喘中的作用:新的治疗靶点。
Chest. 2012 Apr;141(4):886-894. doi: 10.1378/chest.11-0633. Epub 2011 Oct 20.